Amcasertib (BBI503) (C09-0735-571)

Aladdin

Catalog No.: C09-0735-571
Manufacturer No.: A414065-25mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $1,483.08

List Price: $1,647.87

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

InformationAmcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.TargetsNanogIn vitroBBI-503 is orally-administered compound, which is designed to target CSC pathways in multiple tumour types.In vivoBBI503 inhibits Nanog and other cancer stem cell pathways by targeting kinases, and shows encouraging early signs of anti-cancer activity for patients with advanced colorectal cancer. Specification: 0.95 Molecular Formula: C31H33N5O2S Molecular Weight: 539.69 PubChem CID: 74403975 Isomeric SMILES: CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)C4=CSC(=N4)C5=CC=CC=C5)NC2=O)C

UPC:: 12352005
Condition:: New
Availability:: 2 weeks
Weight:: 0.96 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: A414065-25mg
CAS:: 1129403-56-0
Product Size:: 25mg

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."